Home » INVESTBIO VENTURES INVESTS $14 MILLION IN THE VACCINE COMPANY
INVESTBIO VENTURES INVESTS $14 MILLION IN THE VACCINE COMPANY
The Vaccine Company, L.P., an InvestBio Ventures Partnership, announced today
that it has raised $14 million of a planned $20 million investment in The Vaccine
Company
(TVC). This first stage of the investment in TVC was completed on October 17,
2005. InvestPrivate, Inc. acted as the placement agent for the offering. TVC
was formed in July 2003 to commercialize the PR1 vaccine that is being developed
at the MD Anderson Cancer Center at The University of Texas.
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May